Level C· Early human research exploring benefitsProspective StudyPubMed

[Modern technologies of regenerative rehabilitation in the treatment of patients with abnormal scars].

Vasilyev VS., Korchazhkina NB., Mikhailova AA., Nadelyaeva II., Vasilyev SA., Vasilyev IS.

Prospective Study with a reported sample of 118 on Scar, published in Khirurgiia (Mosk) (2021) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Khirurgiia (Mosk) (2021)
Country
Russia (Federation)
Reported sample size
118
Source database
PubMed
PMID
34032783
DOI
10.17116/hirurgia20210627
Citations
5

Abstract (original English)

To evaluate an efficacy of lipoaspirate-based products in pathologic scarring management. There were 118 patients with external scars. Depending on scar type, localization and need for soft tissue augmentation, three different methods were used for lipoaspirate-based product preparation: 15-minute sedimentation, centrifugation at 1200 g for 3 minutes and emulsification with a channel diameter of 1.2 mm. Results were assessed using the Manchester Scar Scale (MSS) and photographing. According to MSS analysis, the following results were obtained: before treatment - 11.6 (9.3-13.3) scores, 3 months after treatment - 6.5 (5.1-7.2) scores, 6 months after treatment - 5.2 (4.5-6.1) scores. Significant differences were obtained for baseline values and both control points. Stable results were obtained in long-term follow-up period (12-24 months). No major adverse effects were observed. Minor complications were registered in 10.1% of patients. Injections of lipoaspirate-based products is an effective option for the treatment of patients with pathologic scarring. This approach is intermediate between conservative and conventional surgical treatment. Оценить эффективность инъекционной аутотрансплантации продуктов на основе липоаспирата в лечении пациентов с патологическими рубцовыми изменениями. В исследование включены 118 пациентов с рубцами наружной локализации. В зависимости от типа и ра

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
CicatrixHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research